Next Breath is a speciality company of Aptar Pharma and a cGMP compliant laboratory located in Baltimore, Maryland. Next Breath is viewed as an intellectual leader in the field of inhalation and nasal spray development, testing and regulatory strategy. Next Breath is an active member of the OINDP community. We participate in seminars and educational workshops at leading conferences (RDD, DDL, IPAC-RS, AAPS and PDA among others). Next Breath also regularly contributes to development of standard practices through leadership in the Inhalation and Nasal Technology Focus Group, OINDP and PDA committees
Since inception, Next Breath has collaborated with over 65 pharmaceutical companies and has contributed towards several successful regulatory submissions in domestic and international markets. Our expertise and results have been used in NDA’s, ANDA’s, 510(k) studies and BLA’s. In addition, Next Breath’s FDA inspected laboratory performs commercial batch release and stability studies for the US market.